Cybin Inc. Files Form 6-K with News Release
Ticker: HELP · Form: 6-K · Filed: Oct 1, 2024 · CIK: 1833141
| Field | Detail |
|---|---|
| Company | Cybin INC. (HELP) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, news-release, pharmaceuticals
TL;DR
Cybin Inc. filed a 6-K on Oct 1, 2024, with a news release attached. CEO Doug Drysdale signed off.
AI Summary
Cybin Inc. filed a Form 6-K on October 1, 2024, reporting a news release dated October 1, 2024. The filing indicates Cybin Inc. is a pharmaceutical preparations company incorporated in A6 with its principal executive offices in Toronto, Ontario. Doug Drysdale, CEO, signed the report.
Why It Matters
This filing provides an update on Cybin Inc.'s corporate activities and regulatory disclosures, which is important for investors tracking the company's progress in the pharmaceutical sector.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- CYBIN INC. (company) — Registrant
- Doug Drysdale (person) — Chief Executive Officer
- October 1, 2024 (date) — Filing date and news release date
- 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 (address) — Principal executive offices
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K filing is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2024, and includes a news release dated October 1, 2024.
Who is the Chief Executive Officer of Cybin Inc. and when did they sign the report?
Doug Drysdale is the Chief Executive Officer of Cybin Inc. and signed the report on October 1, 2024.
What is Cybin Inc.'s fiscal year end?
Cybin Inc.'s fiscal year end is March 31.
What is the SIC code for Cybin Inc.?
The Standard Industrial Classification (SIC) code for Cybin Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What exhibits are included with this Form 6-K filing?
The filing includes Exhibit 99.1, which is a News Release dated October 1, 2024.
Filing Stats: 147 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-10-01 10:58:46
Filing Documents
- cybininc-form6xk10x01x2024.htm (6-K) — 11KB
- a10-01x2024teammembersprfi.htm (EX-99.1) — 22KB
- image_0.jpg (GRAPHIC) — 25KB
- 0001628280-24-041671.txt ( ) — 68KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2024. Commission File Number 001-40673 Cybin Inc. (Exact Name of Registrant as Specified in Charter) 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CYBIN INC. (Registrant) Date October 1, 2024 By s Doug Drysdale Name Doug Drysdale Title Chief Executive Officer EXHIBIT INDEX 99.1 News Release dated October 1, 2024